In critically ill patients with acute renal failure, outcomes, not dollars, should drive modality choice

Critical Care Medicine

Volumn 31, Issue 2, 2003, Pages 644-646

  Mehta, Ravindra L ^a   Chertow, Glenn M ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute renal failure; Continuous renal replacement therapy; Costs; Dialysis; Intensive care unit; Outcomes

Indexed keywords

ANTICOAGULANT AGENT; CITRIC ACID; HEPARIN;

ACUTE KIDNEY FAILURE; ANTICOAGULATION; CANADA; COMORBIDITY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; CRITICAL ILLNESS; DIALYSIS; DISEASE SEVERITY; ECONOMIC ASPECT; EDITORIAL; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEMODIALYSIS; HOSPITAL COST; HOSPITALIZATION; HYPOTENSION; INTENSIVE CARE; KIDNEY TRANSPLANTATION; MEAN ARTERIAL PRESSURE; MEDICAL DECISION MAKING; OUTCOMES RESEARCH; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL MODEL;

COSTS AND COST ANALYSIS; CRITICAL ILLNESS; HUMANS; KIDNEY FAILURE, ACUTE; TREATMENT OUTCOME;

EID: 0037323981     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000045183.74244.14     Document Type: Editorial

References (26)

1. Liano F, Junco E, Pascual J, et al: The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings: The Madrid Acute Renal Failure Study Group. Kidney Int Suppl 1998; 66:S16-S24
2. Cole L, Bellomo R, Silvester W, et al: A prospective, multicenter study of the epidemiology, management, and outcome of severe acute renal failure in a "closed" ICU system. Am J Respir Crit Care Med 2000; 162:191-196
3. Obialo CI, Okonofua EC, Tayade AS, et al: Epidemiology of de novo acute renal failure in hospitalized African Americans: Comparing community-acquired vs hospital-acquired disease. Arch Intern Med 2000; 160:1309-1313
4. de Mendonca A, Vincent JL, Surer PM, et al: Acute renal failure in the ICU: Risk factors and outcome evaluated by the SOFA score. Intensive Care Med 2000; 26:915-921
5. Mehta RL: Indications for dialysis in the ICU: Renal replacement vs. renal support. Blood Purif 2001; 19:227-232
6. Kellum J, Mehta R, Angus D, et al: The First International consensus conference on continuous renal replacement therapy. Kidney Int 2002; 62:1855-1863
7. Bates DW, Su L, Yu DT, et al: Correlates of acute renal failure in patients receiving parenteral amphotericin B. Kidney Int 2001; 60:1452-1459
8. Hamel MB, Phillips RS, Davis RB, et al: Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults: SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med 1997; 127:195-202
9. Korkeila M, Ruokonen E, Takala J: Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care. Intensive Care Med 2000; 26:1824-1831
10. Chertow G: Dialysis: Cost-effective SUPPORT for patients with acute renal failure. Am J Kidney Dis 1998; 31:545-549
11. Gopal I, Bhonagiri S, Ronco C, et al: Out of hospital outcome and quality of life in survivors of combined acute multiple organ and renal failure treated with continuous venovenous hemofiltration/hemodiafiltration. Intensive Care Med 1997; 23:766-772
12. Manns B, Doig CJ, Lee H, et al: Cost of acute renal failure requiring dialysis in the intensive care unit: Clinical and resource implications of renal recovery. Crit Care Med 2003; 31:449-455
13. Mehta RL, McDonald B, Gabbai FB, et al: A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001; 60:1154-1163
14. Ronco C, Bellomo R, Homel P, et al: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000; 356:26-30
15. Swartz RD, Messana JM, Orzol S, et al: Comparing continuous hemofiltration with hemodialysis in patients with severe acute renal failure. Am J Kidney Dis 1999; 34:424-432
16. Mehta RL: Anticoagulation during continuous renal replacement therapy. ASAIO J 1994; 40:931-935
17. Kutsogiannis D, Mayers I, Chin W, et al: Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis 2000; 35:802-811
18. Heyland DK, Gafni A, Kernerman P, et al: How to use the results of an economic evaluation. Crit Care Med 1999; 27:1195-1202
19. Vincent JL: Incidence of acute renal failure in the intensive care unit. Contrib Nephrol 2001; 132:1-6
20. Mehta RL, Pascual MT, Gruta CG, et al: Refining predictive models in critically ill patients with acute renal failure. J Am Soc Nephrol 2002; 13:1350-1357
21. Dunham CM: Clinical impact of continuous renal replacement therapy on multiple organ failure. World J Surg 2001; 25:669-676
22. van der Sande FM, Kooman JP, Barendregt JN, et al: Effect of intravenous saline, albumin, or hydroxyethylstarch on blood volume during combined ultrafiltration and hemodialysis. J Am Soc Nephrol 1999; 10:1303-1308
23. Rosales LM, Schneditz D, Morris AT, et al: Isothermic hemodialysis and ultrafiltration. Am J Kidney Dis 2000; 36:353-361
24. Bos WJ, Bruin S, van Olden RW, et al: Cardiac and hemodynamic effects of hemodialysis and ultrafiltration. Am J Kidney Dis 2000; 35:819-826
25. Schortgen F, Soubrier N, Delclaux C, et al: Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: Usefulness of practice guidelines. Am J Respir Crit Care Med 2000; 162:197-202
26. Morgera S, Kraft AK, Siebert G, et al: Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies. Am J Kidney Dis 2002; 40:275-279